Tailor Bio

Tailor Bio

Private
CambridgeHealthcare & Life Scienceshttps://tailor.bio

Last Round

Seed

Nov 30, 2022

Total Funding Raised

$3.48M

Company Overview

Tailor Bio is a biotechnology company that operates a drug discovery platform intended for pan-cancer precision medicine. The company's platform uses artificial intelligence to identify patterns in tumor DNA to predict a patient's response to cancer drugs, focusing on chromosomal instability (CIN).

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Precision Medicine, Biotechnology, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

ex vivo platformprecision oncologyoncology CROdrug response predictioncontract research organizationCRObiomarker discoverypatient stratificationtumor microenvironmentex vivo drug testingfunctional precision medicinepatient-derived explantstumor organoidsclinical trial supportpreclinical modelsbiopharma servicesmechanism of action validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tailor Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tailor Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedNov 30, 2022
GrantJul 15, 2022
GrantJun 29, 2020
Pre SeedJun 23, 2020

Tailor Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 1069% MoM, reaching 1.1K.

Tailor Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tailor Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tailor Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range21
Year Founded2019
Last FundingNov 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.